AI assistant
Predictive Oncology Inc. — Director's Dealing 2015
Sep 16, 2015
35106_dirs_2015-09-16_e8230cec-0a25-43c5-add9-2987454422b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2015-08-31
Reporting Person: SOK Partners LLC (10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-31 | Senior Convertible Note | $11.25 | J | 1 | Disposed | 2015-07-23 | Common Stock, par value $0.01 per share () | Direct |
Footnotes
F1: On July 23, 2014, the Issuer issued a senior convertible note in the original principal amount of $122,195.60 (the "Note") to SOK Partners, LLC ("SOK Partners"). The Note was convertible at any time after issuance, at the holder's option, into shares of the Company's common stock, par value $0.01 per share (the "Common Stock"), at a conversion price equal to the lesser of (i) 72.5% (or if an event of default has occurred and is continuing, 70%) of the average of the lowest three volume weighted average prices of the Common Stock during the ten consecutive trading days prior to the conversion date, and (ii) $11.25 (as adjusted for stock splits, stock dividends, recapitalizations or similar events). On August 31, 2015, in consideration of the payment by the Issuer of $167,694.12, the outstanding principal, accrued interest and penalties payable under the Note were repaid and the note was cancelled.
F2: The Note was due on July 23, 2015; provided, however, this date may be extended at the option of the holder in accordance with the terms of the Note.